Details for New Drug Application (NDA): 019814
✉ Email this page to a colleague
NDA 019814 describes BETAGAN, which is a drug marketed by Allergan and is included in two NDAs. Additional details are available on the BETAGAN profile page.
The generic ingredient in BETAGAN is levobunolol hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
The generic ingredient in BETAGAN is levobunolol hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for 019814
| Tradename: | BETAGAN |
| Applicant: | Allergan |
| Ingredient: | levobunolol hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019814
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jun 28, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
